Cocrystal(COCP) - 2023 Q1 - Quarterly Report

In September 2021, the Company opened a wholly owned foreign subsidiary in Australia named Cocrystal Pharma Australia, Ltd ("Cocrystal Australia") with the objective of operating clinical trials in Australia. All share and per share amounts have been retroactively restated to reflect the one-for-12 stock split as if it occurred at the beginning of the earliest period presented. Basis of Presentation Cocrystal Australia maintains its records in Australian dollars. The monetary assets and liabilities of Cocry ...